| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2002-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edddb2760b033037e8b99f4f0969d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40dc5a911cc2e8473429df5dcbc6c4d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a169425d46d6b0180310596cbf0dcdbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_240170082bd8a9ba3192f4de9eb61ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8f81a0c28189d206c600fdd2742715b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6661f0ce0466ca0f388a88f6e7a2fa6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bba78f083e46aba60a08bf68ac2381f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ecc2fc35721d07e009c382a2d67427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef64061d411b8dba88d9a3bc5cd2c8e9 |
| publicationDate |
2004-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10246434-A1 |
| titleOfInvention |
Acyl-carboxyphenylurea derivatives, process for their preparation and their use as medicines |
| abstract |
The invention relates to acyl-carboxyphenylurea derivatives and their physiologically tolerable salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the meanings given, and their physiologically tolerable salts and processes for their preparation. The compounds are suitable for. B. for the treatment of type II diabetes. |
| priorityDate |
2002-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |